AT368995B - Verfahren zur herstellung von neuen hexahydro -gamma-carbolinverbindungen und deren salzen - Google Patents

Verfahren zur herstellung von neuen hexahydro -gamma-carbolinverbindungen und deren salzen

Info

Publication number
AT368995B
AT368995B AT0369678A AT369678A AT368995B AT 368995 B AT368995 B AT 368995B AT 0369678 A AT0369678 A AT 0369678A AT 369678 A AT369678 A AT 369678A AT 368995 B AT368995 B AT 368995B
Authority
AT
Austria
Prior art keywords
carbolin
gamma
salts
compounds
producing new
Prior art date
Application number
AT0369678A
Other languages
German (de)
English (en)
Other versions
ATA369678A (de
Inventor
Willard Mckowan Welch Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to AT444080A priority Critical patent/AT368996B/de
Priority to AT444180A priority patent/AT375079B/de
Publication of ATA369678A publication Critical patent/ATA369678A/de
Application granted granted Critical
Publication of AT368995B publication Critical patent/AT368995B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
AT0369678A 1977-05-23 1978-05-22 Verfahren zur herstellung von neuen hexahydro -gamma-carbolinverbindungen und deren salzen AT368995B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT444080A AT368996B (de) 1977-05-23 1980-09-03 Verfahren zur herstellung von neuen hexahydro -gamma-carbolinverbindungen
AT444180A AT375079B (de) 1977-05-23 1980-09-03 Verfahren zur herstellung von neuen trans-2,3,4,4a ,5,9b-hexahydro-1h-pyrido(4,3-b)indolen und ihren pharmazeutisch annehmbaren salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79939277A 1977-05-23 1977-05-23

Publications (2)

Publication Number Publication Date
ATA369678A ATA369678A (de) 1982-04-15
AT368995B true AT368995B (de) 1982-11-25

Family

ID=25175793

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0369678A AT368995B (de) 1977-05-23 1978-05-22 Verfahren zur herstellung von neuen hexahydro -gamma-carbolinverbindungen und deren salzen

Country Status (31)

Country Link
JP (1) JPS53144600A (es)
AR (2) AR217688A1 (es)
AT (1) AT368995B (es)
AU (1) AU499618B1 (es)
BE (1) BE867249A (es)
CA (1) CA1094071A (es)
CH (1) CH634321A5 (es)
CS (1) CS207612B2 (es)
DD (4) DD146186A5 (es)
DE (1) DE2822465C2 (es)
DK (1) DK226678A (es)
EG (1) EG13590A (es)
FI (1) FI63402C (es)
FR (1) FR2392023A1 (es)
GB (1) GB1586655A (es)
GR (1) GR69985B (es)
HU (3) HU185009B (es)
IE (1) IE46975B1 (es)
IL (1) IL54755A (es)
IT (1) IT1096307B (es)
LU (1) LU79684A1 (es)
NL (1) NL7804210A (es)
NO (2) NO150204C (es)
NZ (1) NZ187333A (es)
PH (1) PH13756A (es)
PL (5) PL117107B1 (es)
PT (1) PT68058B (es)
SE (2) SE441448B (es)
SU (4) SU873883A3 (es)
YU (4) YU91478A (es)
ZA (1) ZA782918B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
RU2106864C1 (ru) * 1995-10-23 1998-03-20 Николай Серафимович Зефиров Средство для лечения болезни альцгеймера
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
SE9604786D0 (sv) * 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0101770D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (es) * 1974-03-20 1975-10-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines

Also Published As

Publication number Publication date
EG13590A (en) 1982-03-31
DD145537A5 (de) 1980-12-17
IL54755A (en) 1981-02-27
LU79684A1 (fr) 1979-12-06
FI63402B (fi) 1983-02-28
YU221782A (en) 1983-01-21
DD138321A5 (de) 1979-10-24
IT1096307B (it) 1985-08-26
NO150204B (no) 1984-05-28
ATA369678A (de) 1982-04-15
HU185009B (en) 1984-11-28
BE867249A (fr) 1978-11-20
PT68058A (en) 1978-06-01
AR217688A1 (es) 1980-04-15
DE2822465A1 (de) 1978-11-30
HU187782B (en) 1986-02-28
DD145536A5 (de) 1980-12-17
NO151862C (no) 1985-06-19
PL114547B1 (en) 1981-02-28
NO150204C (no) 1984-09-05
CS207612B2 (en) 1981-08-31
SU841589A3 (ru) 1981-06-23
PL114541B1 (en) 1981-02-28
SU843749A3 (ru) 1981-06-30
YU221682A (en) 1983-01-21
DD146186A5 (de) 1981-01-28
ZA782918B (en) 1979-06-27
SE8305917D0 (sv) 1983-10-27
NZ187333A (en) 1984-05-31
AU499618B1 (en) 1979-04-26
SE8305917L (sv) 1983-10-27
NO831790L (no) 1978-11-24
HU188802B (en) 1986-05-28
YU40796B (en) 1986-06-30
PL206903A1 (pl) 1979-10-22
SE7803625L (sv) 1978-11-24
JPS5711912B2 (es) 1982-03-08
PL116944B1 (en) 1981-07-31
JPS53144600A (en) 1978-12-15
FR2392023A1 (fr) 1978-12-22
IT7823673A0 (it) 1978-05-22
NO151862B (no) 1985-03-11
PH13756A (en) 1980-09-17
PT68058B (en) 1979-10-24
FI781612A (fi) 1978-11-24
GB1586655A (en) 1981-03-25
SU873883A3 (ru) 1981-10-15
IE46975B1 (en) 1983-11-16
YU221882A (en) 1983-01-21
YU91478A (en) 1983-01-21
SE441448B (sv) 1985-10-07
NL7804210A (nl) 1978-11-27
FR2392023B1 (es) 1980-11-07
DK226678A (da) 1978-11-24
SU818484A3 (ru) 1981-03-30
NO781770L (no) 1978-11-24
DE2822465C2 (de) 1986-08-28
FI63402C (fi) 1983-06-10
IL54755A0 (en) 1978-07-31
PL117107B1 (en) 1981-07-31
CH634321A5 (en) 1983-01-31
CA1094071A (en) 1981-01-20
SE448459B (sv) 1987-02-23
GR69985B (es) 1982-07-22
AR221721A1 (es) 1981-03-13
IE781013L (en) 1978-11-23

Similar Documents

Publication Publication Date Title
ATA601078A (de) Verfahren zur herstellung von neuen nitro- imidazolen und von deren salzen
AT364851B (de) Verfahren zur herstellung von neuen thienothiazinderivaten und von deren salzen
AT363952B (de) Verfahren zur herstellung von neuen triazinverbindungen und deren salzen
AT371454B (de) Verfahren zur herstellung von neuen prostanderivaten und von deren salzen
AT366043B (de) Verfahren zur herstellung von neuen chinazolinderivaten und deren salzen
AT361139B (de) Verfahren zur herstellung von neuen morphin- derivaten und von deren salzen
AT367044B (de) Verfahren zur herstellung von neuen 2-aminound/oder 4-amino-5-alkylthiopyrimidinen und deren salzen
AT368995B (de) Verfahren zur herstellung von neuen hexahydro -gamma-carbolinverbindungen und deren salzen
AT365188B (de) Verfahren zur herstellung von neuen 7-azabenzimidazolen und deren salzen
AT371112B (de) Verfahren zur herstellung von neuen 2-imino-imidazolidin-derivaten und von deren salzen
AT363937B (de) Verfahren zur herstellung von neuen bispidinderivaten und deren salzen
AT360664B (de) Verfahren zur herstellung von neuen morphin- derivaten und von deren salzen
ATA747378A (de) Verfahren zur herstellung von neuen 1-aryl-alkyl-imidazolderivaten und deren salzen
AT362355B (de) Verfahren zur herstellung von neuen dithienyl (3)-verbindungen und deren salzen
ATA57578A (de) Verfahren zur herstellung von neuen azacycloalkanen und azacycloalkenen und deren derivaten und salzen
AT367410B (de) Verfahren zur herstellung von neuen 2-benzazepin- verbindungen und deren salzen
AT360999B (de) Verfahren zur herstellung von neuen amidino- -benzylpyrimidinen und deren salzen
AT365183B (de) Verfahren zur herstellung von neuen 4-amino-2-piperidinochinazolinderivaten und deren salzen
AT358050B (de) Verfahren zur herstellung von neuen triazolo- thieno-diazepin-1-onen und deren salzen
ATA320578A (de) Verfahren zur herstellung von neuen benzylpyrimidinen und deren salzen
ATA73877A (de) Verfahren zur herstellung von neuen oxadiazolopyrimidinderivaten und von deren salzen
AT363466B (de) Verfahren zur herstellung von imidazolinderivaten und von deren salzen
ATA356778A (de) Verfahren zur herstellung von neuen 4-hydroxy- thiazolidin-2-thion-derivaten und von deren salzen
AT358731B (de) Verfahren zur herstellung von cyanacetamid- -derivaten und deren salzen
ATA614779A (de) Verfahren zur herstellung von neuen triazolo- -thieno-diazepin-1-onen und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee